Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

07. März 2013 08:30 ET | Quelle: EDAP TMS S.A.

EDAP Receives U.S. FDA Administrative Acceptance Review Notification for Ablatherm(R)-HIFU Pre-Market Approval Application

LYON, France, March 7, 2013 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that the U.S. Food and Drug Administration (FDA) has provided a...
22. Februar 2013 08:30 ET | Quelle: EDAP TMS S.A.

EDAP's Ablatherm-HIFU Offers Reliable Therapy for Localized Prostate Cancer

LYON, France, Feb. 22, 2013 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today new long term data demonstrating high rates of both...
08. Februar 2013 08:30 ET | Quelle: EDAP TMS S.A.

EDAP's Ablatherm-HIFU Demonstrates Long-Term Efficacy and Safety Over Fourteen-Year Period

LYON, France, Feb. 8, 2013 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today new data demonstrating the safety and long-term efficacy of...
01. Februar 2013 08:30 ET | Quelle: EDAP TMS S.A.

EDAP Submits U.S. FDA Pre-Market Approval Application for Ablatherm(R)-HIFU for Treatment of Low Risk, Localized Prostate Cancer

LYON, France, Feb. 1, 2013 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today the submission of its Pre-Market Approval (PMA) application to...
22. Januar 2013 08:00 ET | Quelle: EDAP TMS S.A.

EDAP Reports 25% Year-Over-Year Revenue Growth for Fourth Quarter 2012

Record full year revenue of approximately EUR 26.0 million (USD 33.5 million), up 16.5% year-over-year Record fourth quarter total revenue of approximately EUR 9.4 million (USD 12.2 million), up...
21. November 2012 07:00 ET | Quelle: EDAP TMS S.A.

EDAP Reports Third Quarter 2012 Results

Recent Highlights Recorded robust 13% sales growth over the nine-month period Strong lithotripsy sales in third quarter and replenished fourth quarter device backlog in lithotripsy and...
07. November 2012 08:30 ET | Quelle: EDAP TMS S.A.

EDAP Schedules Webcast and Conference Call for Third Quarter 2012 Results

LYON, France, Nov. 7, 2012 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its third quarter 2012 results announcement,...
25. Oktober 2012 08:30 ET | Quelle: EDAP TMS S.A.

EDAP Highlights HIFU Expertise at Third International Symposium on Focused Ultrasound in Washington, D.C.

LYON, France, Oct. 25, 2012 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced its recent participation at the Third International Symposium on...
09. Oktober 2012 08:30 ET | Quelle: EDAP TMS S.A.

EDAP Appoints Experienced Lithotripsy Expert to Increase U.S. Sales

LYON, France, Oct. 9, 2012 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today the appointment of Bill Brown as U.S. based Senior Sales Manager....
30. August 2012 07:00 ET | Quelle: EDAP TMS S.A.

EDAP Reports Second Quarter 2012 Revenues Up 61%

Second Quarter 2012 Highlights Revenues increased 61% year-over-year to EUR 6.1 million (USD 7.8 million) Strong lithotripsy sales with fourteen devices sold globally Strengthened third...

Vorherige Seite

Nächste Seite